Related references
Note: Only part of the references are listed.Disparities in Genetic Testing for Heritable Solid-Tumor Malignancies
Jacquelyn Dillon et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2022)
A review of the cost-effectiveness of genetic testing for germline variants in familial cancer
Srinivas Teppala et al.
JOURNAL OF MEDICAL ECONOMICS (2022)
Predictors of adherence and the role of primary non-adherence in antihormonal treatment of breast cancer
Ida Dragvoll et al.
BMC CANCER (2022)
The development of the Clinician-reported Genetic testing Utility InDEx (C-GUIDE): a novel strategy for measuring the clinical utility of genetic testing
R. Z. Hayeems et al.
GENETICS IN MEDICINE (2020)
Identifying the key characteristics of clinical fear of cancer recurrence: An international Delphi study
Brittany Mutsaers et al.
PSYCHO-ONCOLOGY (2020)
The contemporary landscape of genetic testing and breast cancer: Emerging issues
Payal D. Shah et al.
BREAST JOURNAL (2020)
Racial differences in genomic testing and receipt of endocrine therapy in early-stage breast cancer
Naomi Y. Ko et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
N. Tarazona et al.
ANNALS OF ONCOLOGY (2019)
A prospective decision-impact study incorporating Breast Cancer Index into extended endocrine therapy decision-making
Tara Sanft et al.
BREAST CANCER MANAGEMENT (2019)
Increasing confidence and changing behaviors in primary care providers engaged in genetic counselling
Michael S. Wilkes et al.
BMC MEDICAL EDUCATION (2017)
What Is Clinical Utility and Why Should We Care?
L. J. Lesko et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Share Paper
